Central Sensitization (CS) has been proposed as a common neurophysiological phenomenon to explain related syndromes for which no specific organic cause can be found.(1) The term Central Sensitivity Syndrome (CSS) is a newly proposed category for a group of inter-related disorders for which CS is a common etiology, including:(1,2)
- The Central Sensitization Inventory A User's Manual Free
- The Central Sensitization Inventory A User's Manual 2016
The Central Sensitization Inventory A User's Manual Free
Jan 02, 2014 Aside from offering a top shelf review of true central sensitisation, L&W present to us a challenging reality – that central sensitisation causes allodynia and hyperalgesia in the problem area (primary allodynia and hyperalgesia) and the surrounding tissue (secondary.), but it does not cause reduced pain thresholds, temporal wind-up. The central sensitization inventory: A user’s manual Randy Neblett PRIDE Research Foundation, Dallas, TX, USA Correspondence Randy Neblett, PRIDE, Dallas, TX, USA. Email: randyneblett@pridedallas.com The Central Sensitization (CSI) Inventory was introduced in 2012. It was initially intended as a screener to help iden - tify when presenting. Sep 25, 2017 The Central Sensitization Inventory (CSI) September 25, 2017 Brett Jarosz Central Sensitization (CS) has been proposed as a common neurophysiological phenomenon to explain related syndromes for which no specific organic cause can be found.(1) The term Central Sensitivity Syndrome (CSS) is a newly proposed category for a group of inter-related. BACKGROUND: The Central Sensitization Inventory (CSI) and Pain Sensitivity Questionnaire (PSQ) are alternatives to quantitative sensory testing (QST) for inferring central sensitization. OBJECTIVE: Explore 1) comparative validity of the CSI and PSQ with QST (construct validity) and pain-related psychological questionnaires (concurrent validity), and 2) associations with widespread pain sensitivity. In 2012 Mayer et al. Proposed the Central Sensitization Inventory (CSI). The clinical goal of this screening instrument is to help better assess symptoms thought to be associated with CS in order to aid physicians and other clinicians in syndrome categorization, sensitivity, severity identification, and treatment planning, to help minimize, or possibly avoid, unnecessary diagnostics and treatment procedures. Purposing: The Central Sensitization Inventory (CSI) is a new patient‑reported instrument, which measures symp‑ toms related to Central Sensitivity Syndromes and Central Sensitization.
- Fibromyalgia
- Myofascial Pain Syndrome
- Chronic Fatigue Syndrome
- Temporomandibular Joint Disorder
- Irritable Bowel Syndrome
- Migraine/Tension Type Headaches
- Restless Leg Syndrome
- Multiple Chemical Sensitivity
The Central Sensitization Inventory (CSI) was developed by Mayer et al (1) in 2012 to assess the overlapping health-related symptom dimensions of CS/CSSs. It was originally designed as a screening instrument to help identify when a patient’s presenting symptoms may indicate the presence of a CSS diagnosis, so that potentially unnecessary diagnostic and treatment procedures can be avoided, and biopsychosocial treatment planning can be initiated.
The CSI has been found to have a high degree of test-retest reliability and internal consistency.(1) A 2017 systematic review looking at the measurement properties of the CSI concluded “…the tool generates reliable and valid data that quantifies the severity of several symptoms of CS.”(3)
A 2015 study found that patients with high CSI scores (>40) before knee replacement reported more severe postsurgical pain intensity, required higher dosage of postsurgical analgesics, and were at higher risk of persistent pain 3 months later.(5) Use of the CSI, with the 40-point cut-off score, has also been recommended to help classify chronic pain patients with CS, and to help differentiate them from patients with neuropathic and nocioceptive pain.(6,7)
Total scores on the CSI range from 0-100, with the following severity ranges recommended:
- Subclinical = 0 to 29;
- Mild = 30 to 39;
- Moderate = 40 to 49;
- Severe = 50 to 59;
- Extreme = 60 to 100.
A 2017 study provided “support for these CSI severity levels as a guideline for healthcare providers and researchers in interpreting CSI scores and evaluating treatment responsiveness.”(4)
In summary, the CSI is appropriate for clinical purposes with higher CSI scores, indicating a higher probability of CS. Additionally, a CSI score of >40-points is clinically significant, providing both good sensitivity and specificity for the presence of CSS.
Easily administer, score and interpret outcome measures – including the CSI – through Erepsonline. For more information on selecting and viewing outcome measures, see the Erepsonline Video Tutorials, or check out the Quick Start Guide
References:
- Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012 Apr;12(4):276–85.
- PRIDE; c2017 [cited 2017 September 13]. Available from: https://www.pridedallas.com/questionnaires/
- Scerbo T, Colasurdo J, Dunn S, Unger J, Nijs J, Cook C. Measurement Properties of the Central Sensitization Inventory: A Systematic Review. Pain Pract. 2017 Aug 29.
- Neblett R, Hartzell MM, Mayer TG, Cohen H, Gatchel RJ. Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory. Pain Pract. 3rd ed. 2017 Feb 1;17(2):166–75.
- Kim SH, Yoon KB, Yoon DM, Yoo JH, Ahn KR. Influence of centrally mediated symptoms on postoperative pain in osteoarthritis patients undergoing total knee arthro- plasty: a prospective observational evaluation. Pain Pract. 2015;15:E46–E53.
- Nijs J, Torres-Cueco R, van Wilgen CP, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician. 2014;17:447–457.
- Nijs J, Apeldoorn A, Hallegraeff H, et al. Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain. Pain Physician. 2015;18:E333–E346.
For the Central Sensitization Inventory, Click Here. In languages other than English, Click Here.
I have around 100 of these symptoms, ranging from mild to severe and at various stages of exposure. This is how CSS becomes debilitating, not just from one severe symptom, but from MANY symptoms occurring at the same time, or in the same day, with multiple levels of severity.
The Central Sensitization Inventory A User's Manual 2016
For ease in printing, this form is available PDF format. Please indicate on a scale of 1 to 10, with 10 being the most severe, the severity of each symptom you experience (using the past month as a general guide). If you do not have the symptom, leave the space blank. GENERAL PAIN GENERAL NEUROLOGICAL EQUILIBRIUM/PERCEPTION SLEEP MOOD/EMOTIONS EYES AND VISION SENSITIVITIES UROGENITAL GASTROINTESTINAL SKIN ____ Rashes or sores OTHER COGNITIVE |